At UroGen, making the impossible possible for patients with urological cancers is a reality, not just an idea.
Location: United States, New Jersey, Princeton
Employees: 51-200
Total raised: $75M
Founded date: 2004
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2021 | - | $75M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 18.03.2021 | UroGen Pharma Reports Fourth Quarter and Full Year 2020 Fina... | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 18, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceut... | oaoa.com/n... |
| 18.03.2021 | UroGen Pharma Announces $75 Million of Non-Dilutive Funding ... | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 18, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceut... | oaoa.com/n... |
| 15.03.2021 | UroGen Pharma Announces Sponsored Research Agreement with th... | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 15, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceut... | oaoa.com/n... |
| 11.03.2021 | UroGen Pharma to Report Fourth Quarter and Full Year 2020 Fi... | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 11, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceut... | oaoa.com/n... |
| 05.05.2017 | Term Sheet — Friday, May 5 | CRYPTO-SPLAINING Last week a very confusing press release crossed my radar. It read: “The Argon Gro... | fortune.co... |
| 04.05.2017 | Term Sheet — Thursday, May 4 | ET CETERA New money: Heap, an analytics software company, has raised $27 million in Series B fundin... | fortune.co... |
| 25.04.2017 | Term Sheet — Tuesday, April 25 | MONEY-LOSING HOUSE OF HORRORS Contrarian: The message around Cloudera’s IPO, which is expected to p... | fortune.co... |
| - | The next frontier in bladder cancer treatment | The future landscape according to urologic oncology experts November is National Bladder Health Mon... | statnews.c... |
| - | UroGen Pharma Announces Inducement Grant Under Nasdaq Listin... | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 5, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN) a biopharmaceutic... | oaoa.com/n... |
| - | Innovations in uro-oncology: How can we ensure that no patie... | By Liz Barrett, UroGen Pharma, President and Chief Executive Officer We live in an exciting era in ... | statnews.c... |
Show more